Thomas Jefferson University

Shunji Tomatsu

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentFaculty Records and Publicatio - Thomas Jefferson University
Address833 Chestnut Street
Philadelphia PA 19107
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Herre?o-Pach?n AM, Sawamoto K, Stapleton M, Khan S, Piechnik M, ?lvarez JV, Tomatsu S. Adeno-Associated Virus Gene Transfer Ameliorates Progression of Skeletal Lesions in Mucopolysaccharidosis IVA Mice. Hum Gene Ther. 2024 Oct 25. PMID: 39450470.
      Citations:    
    2. Celik B, Rintz E, Sansanwal N, Khan S, Bigger B, Tomatsu S. Lentiviral Vector-Mediated Ex Vivo Hematopoietic Stem Cell Gene Therapy for Mucopolysaccharidosis IVA Murine Model. Hum Gene Ther. 2024 Oct 24. PMID: 39446675.
      Citations:    
    3. Celik B, Leal AF, Tomatsu S. Potential Targeting Mechanisms for Bone-Directed Therapies. Int J Mol Sci. 2024 Jul 30; 25(15). PMID: 39125906.
      Citations:    
    4. Khan SA, Nidhi F, Leal AF, Celik B, Herre?o-Pach?n AM, Saikia S, Benincore-Fl?rez E, Ago Y, Tomatsu S. Glycosaminoglycans in mucopolysaccharidoses and other disorders. Adv Clin Chem. 2024; 122:1-52. PMID: 39111960.
      Citations:    
    5. Pimentel-Vera LN, Rodr?guez-L?pez A, Espejo-Mojica AJ, Ram?rez AM, Cardona C, Reyes LH, Tomatsu S, Jaroentomeechai T, DeLisa MP, S?nchez OF, Alm?ciga-D?az CJ. Novel human recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in a glyco-engineered Escherichia coli strain. Heliyon. 2024 Jun 30; 10(12):e32555. PMID: 38952373.
      Citations:    
    6. Pan X, Caillon A, Fan S, Khan S, Tomatsu S, Pshezhetsky AV. Heterologous HSPC Transplantation Rescues Neuroinflammation and Ameliorates Peripheral Manifestations in the Mouse Model of Lysosomal Transmembrane Enzyme Deficiency, MPS IIIC. Cells. 2024 May 20; 13(10). PMID: 38786099.
      Citations:    
    7. Rintz E, Celik B, Fnu N, Herre?o-Pach?n AM, Khan S, Benincore-Fl?rez E, Tomatsu S. Molecular therapy and nucleic acid adeno-associated virus-based gene therapy delivering combinations of two growth-associated genes to MPS IVA mice. Mol Ther Nucleic Acids. 2024 Jun 11; 35(2):102211. PMID: 38831899.
      Citations:    
    8. ?lvarez JV, Bravo SB, Chantada-V?zquez MP, Pena C, Col?n C, Tomatsu S, Otero-Espinar FJ, Couce ML. Morquio A Syndrome: Identification of Differential Patterns of Molecular Pathway Interactions in Bone Lesions. Int J Mol Sci. 2024 Mar 12; 25(6). PMID: 38542208.
      Citations:    
    9. Donsante S, Pievani A, Palmisano B, Finamore M, Fazio G, Corsi A, Biondi A, Tomatsu S, Piazza R, Serafini M, Riminucci M. Modeling skeletal dysplasia in Hurler syndrome using patient-derived bone marrow osteoprogenitor cells. JCI Insight. 2024 Mar 08; 9(5). PMID: 38456506.
      Citations:    
    10. Leal AF, Herreno-Pach?n AM, Benincore-Fl?rez E, Karunathilaka A, Tomatsu S. Current Strategies for Increasing Knock-In Efficiency in CRISPR/Cas9-Based Approaches. Int J Mol Sci. 2024 Feb 20; 25(5). PMID: 38473704.
      Citations:    
    11. Ago Y, Rintz E, Musini KS, Ma Z, Tomatsu S. Molecular Mechanisms in Pathophysiology of Mucopolysaccharidosis and Prospects for Innovative Therapy. Int J Mol Sci. 2024 Jan 17; 25(2). PMID: 38256186.
      Citations:    
    12. Leal AF, Alm?ciga-D?az CJ, Tomatsu S. Mucopolysaccharidosis IVA: Current Disease Models and Drawbacks. Int J Mol Sci. 2023 Nov 09; 24(22). PMID: 38003337.
      Citations:    
    13. Leal AF, Celik B, Fnu N, Khan S, Tomatsu S, Alm?ciga-D?az CJ. Iron oxide-coupled CRISPR-nCas9-based genome editing assessment in mucopolysaccharidosis IVA mice. Mol Ther Methods Clin Dev. 2023 Dec 14; 31:101153. PMID: 38107675.
      Citations:    
    14. Leal AF, Inci OK, Seyrantepe V, Rintz E, Celik B, Ago Y, Le?n D, Suarez DA, Alm?ciga-D?az CJ, Tomatsu S. Molecular Trojan Horses for treating lysosomal storage diseases. Mol Genet Metab. 2023 Jun 30; 140(3):107648. PMID: 37598508.
      Citations:    
    15. Rintz E, Herre?o-Pach?n AM, Celik B, Nidhi F, Khan S, Benincore-Fl?rez E, Tomatsu S. Bone Growth Induction in Mucopolysaccharidosis IVA Mouse. Int J Mol Sci. 2023 Jun 08; 24(12). PMID: 37373036.
      Citations:    
    16. Theroux MC, DiCindio S, Averill LW, Pizarro C, Oommen A, Bober MB, Ditro C, Campbell J, Duker AL, Jones T, Passi V, Barth P, Schmidt RJ, Little M, Mackenzie S, Tomatsu S, Mackenzie WG. Tracheal Narrowing and Its Impact on Anesthesia Care in Patients With Morquio A (Mucopolysaccharidosis Type IVA): An Observational Study. Anesth Analg. 2023 Nov 01; 137(5):1075-1083. PMID: 37862598.
      Citations:    
    17. Khan SA, Nidhi FNU, Amendum PC, Tomatsu S. Detection of Glycosaminoglycans in Biological Specimens. Methods Mol Biol. 2023; 2619:3-24. PMID: 36662458.
      Citations:    
    18. Leal AF, Benincore-Fl?rez E, Rintz E, Herre?o-Pach?n AM, Celik B, Ago Y, Alm?ciga-D?az CJ, Tomatsu S. Mucopolysaccharidoses: Cellular Consequences of Glycosaminoglycans Accumulation and Potential Targets. Int J Mol Sci. 2022 Dec 28; 24(1). PMID: 36613919.
      Citations:    
    19. Leal AF, Fnu N, Benincore-Fl?rez E, Herre?o-Pach?n AM, Echeverri-Pe?a OY, Alm?ciga-D?az CJ, Tomatsu S. The landscape of CRISPR/Cas9 for inborn errors of metabolism. Mol Genet Metab. 2023 01; 138(1):106968. PMID: 36525790.
      Citations:    
    20. Jalal K, Carter RL, Barczykowski A, Tomatsu S, Langan TJ. A Roadmap for Potential Improvement of Newborn Screening for Inherited Metabolic Diseases Following Recent Developments and Successful Applications of Bivariate Normal Limits for Pre-Symptomatic Detection of MPS I, Pompe Disease, and Krabbe Disease. Int J Neonatal Screen. 2022 Nov 15; 8(4). PMID: 36412587.
      Citations:    
    21. Piechnik M, Amendum PC, Sawamoto K, Stapleton M, Khan S, Fnu N, ?lvarez V, Pachon AMH, Danos O, Bruder JT, Karumuthil-Melethil S, Tomatsu S. Sex Difference Leads to Differential Gene Expression Patterns and Therapeutic Efficacy in Mucopolysaccharidosis IVA Murine Model Receiving AAV8 Gene Therapy. Int J Mol Sci. 2022 Oct 21; 23(20). PMID: 36293546.
      Citations:    
    22. Celik B, Cicek K, Leal AF, Tomatsu S. Regulation of Molecular Targets in Osteosarcoma Treatment. Int J Mol Sci. 2022 Oct 20; 23(20). PMID: 36293439.
      Citations:    
    23. Pan X, Taherzadeh M, Bose P, Heon-Roberts R, Nguyen ALA, Xu T, Par? C, Yamanaka Y, Priestman DA, Platt FM, Khan S, Fnu N, Tomatsu S, Morales CR, Pshezhetsky AV. Glucosamine amends CNS pathology in mucopolysaccharidosis IIIC mouse expressing misfolded HGSNAT. J Exp Med. 2022 08 01; 219(8). PMID: 35704026.
      Citations:    
    24. Rintz E, Wegrzyn G, Fujii T, Tomatsu S. Molecular Mechanism of Induction of Bone Growth by the C-Type Natriuretic Peptide. Int J Mol Sci. 2022 May 25; 23(11). PMID: 35682595.
      Citations:    
    25. Poletto E, Colella P, Pimentel Vera LN, Khan S, Tomatsu S, Baldo G, Gomez-Ospina N. Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation. Mol Ther Methods Clin Dev. 2022 Jun 09; 25:392-409. PMID: 35573043.
      Citations:    
    26. Rintz E, Higuchi T, Kobayashi H, Galileo DS, Wegrzyn G, Tomatsu S. Promoter considerations in the design of lentiviral vectors for use in treating lysosomal storage diseases. Mol Ther Methods Clin Dev. 2022 Mar 10; 24:71-87. PMID: 34977274.
      Citations:    
    27. Can NTB, Tran DM, Bui TP, Nguyen KN, Nguyen HH, Nguyen TV, Hwu WL, Tomatsu S, Vu DC. Molecular Analysis of Vietnamese Patients with Mucopolysaccharidosis Type I. Life (Basel). 2021 Oct 30; 11(11). PMID: 34833038.
      Citations:    
    28. Chen H, Khan S, Celik B, Suzuki Y, Ago Y, Tomatsu S. Activity of daily living in mucopolysaccharidosis IVA patients: Evaluation of therapeutic efficacy. Mol Genet Genomic Med. 2021 11; 9(11):e1806. PMID: 34623762.
      Citations:    
    29. Amendum PC, Khan S, Yamaguchi S, Kobayashi H, Ago Y, Suzuki Y, Celik B, Rintz E, Hossain J, Xiao W, Tomatsu S. Glycosaminoglycans as Biomarkers for Mucopolysaccharidoses and Other Disorders. Diagnostics (Basel). 2021 Aug 28; 11(9). PMID: 34573906.
      Citations:    
    30. Arunkumar N, Vu DC, Khan S, Kobayashi H, Ngoc Can TB, Oguni T, Watanabe J, Tanaka M, Yamaguchi S, Taketani T, Ago Y, Ohnishi H, Saikia S, ?lvarez JV, Tomatsu S. Diagnosis of Mucopolysaccharidoses and Mucolipidosis by Assaying Multiplex Enzymes and Glycosaminoglycans. Diagnostics (Basel). 2021 Jul 27; 11(8). PMID: 34441282.
      Citations:    
    31. ?lvarez JV, Bravo SB, Chantada-V?zquez MP, Barbosa-Gouveia S, Col?n C, L?pez-Suarez O, Tomatsu S, Otero-Espinar FJ, Couce ML. Plasma Proteomic Analysis in Morquio A Disease. Int J Mol Sci. 2021 Jun 07; 22(11). PMID: 34200496.
      Citations:    
    32. Ratnagiri MV, Zhu Y, Rahman T, Theroux M, Tomatsu S, Shaffer TH. Automated Assessment of Thoracic-Abdominal Asynchrony in Patients with Morquio Syndrome. Diagnostics (Basel). 2021 May 15; 11(5). PMID: 34063456.
      Citations:    
    33. Averill LW, Kecskemethy HH, Theroux MC, Mackenzie WG, Pizarro C, Bober MB, Ditro CP, Tomatsu S. Tracheal narrowing in children and adults with mucopolysaccharidosis type IVA: evaluation with computed tomography angiography. Pediatr Radiol. 2021 Jun; 51(7):1202-1213. PMID: 33608742.
      Citations:    
    34. ?elik B, Tomatsu SC, Tomatsu S, Khan SA. Epidemiology of Mucopolysaccharidoses Update. Diagnostics (Basel). 2021 Feb 10; 11(2). PMID: 33578874.
      Citations:    
    35. ?lvarez VJ, Bravo SB, Chantada-Vazquez MP, Col?n C, De Castro MJ, Morales M, Vitoria I, Tomatsu S, Otero-Espinar FJ, Couce ML. Characterization of New Proteomic Biomarker Candidates in Mucopolysaccharidosis Type IVA. Int J Mol Sci. 2020 Dec 28; 22(1). PMID: 33379360.
      Citations:    
    36. Kubaski F, Sousa I, Amorim T, Pereira D, Trometer J, Souza A, Ranieri E, Polo G, Burlina A, Brusius-Facchin AC, Netto ABO, Tomatsu S, Giugliani R. Neonatal Screening for MPS Disorders in Latin America: A Survey of Pilot Initiatives. Int J Neonatal Screen. 2020 Nov 13; 6(4). PMID: 33203019.
      Citations:    
    37. Sawamoto K, ?lvarez JV, Herre?o AM, Otero-Espinar FJ, Couce ML, Alm?ciga-D?az CJ, Tomatsu S. Bone-Specific Drug Delivery for Osteoporosis and Rare Skeletal Disorders. Curr Osteoporos Rep. 2020 10; 18(5):515-525. PMID: 32845464.
      Citations:    
    38. Wolfberg J, Chintalapati K, Tomatsu S, Nagao K. Hearing Loss in Mucopolysaccharidoses: Current Knowledge and Future Directions. Diagnostics (Basel). 2020 Aug 04; 10(8). PMID: 32759694.
      Citations:    
    39. Sawamoto K, Karumuthil-Melethil S, Khan S, Stapleton M, Bruder JT, Danos O, Tomatsu S. Liver-Targeted AAV8 Gene Therapy Ameliorates Skeletal and Cardiovascular Pathology in a Mucopolysaccharidosis IVA Murine Model. Mol Ther Methods Clin Dev. 2020 Sep 11; 18:50-61. PMID: 32577432.
      Citations:    
    40. Piechnik M, Sawamoto K, Ohnishi H, Kawamoto N, Ago Y, Tomatsu S. Evading the AAV Immune Response in Mucopolysaccharidoses. Int J Mol Sci. 2020 May 13; 21(10). PMID: 32414007.
      Citations:    
    41. Santi L, De Ponti G, Dina G, Pievani A, Corsi A, Riminucci M, Khan S, Sawamoto K, Antolini L, Gregori S, Annoni A, Biondi A, Quattrini A, Tomatsu S, Serafini M. Neonatal combination therapy improves some of the clinical manifestations in the Mucopolysaccharidosis type I murine model. Mol Genet Metab. 2020 07; 130(3):197-208. PMID: 32439268.
      Citations:    
    42. Wang Z, Xu Y, Jiang E, Wang J, Tomatsu S, Shen K. Pathophysiology of Hip Disorders in Patients with Mucopolysaccharidosis IVA. Diagnostics (Basel). 2020 Apr 29; 10(5). PMID: 32365519.
      Citations:    
    43. Arunkumar N, Langan TJ, Stapleton M, Kubaski F, Mason RW, Singh R, Kobayashi H, Yamaguchi S, Suzuki Y, Orii K, Orii T, Fukao T, Tomatsu S. Newborn screening of mucopolysaccharidoses: past, present, and future. J Hum Genet. 2020 Jul; 65(7):557-567. PMID: 32277174.
      Citations:    
    44. Khan SA, Mason RW, Kobayashi H, Yamaguchi S, Tomatsu S. Advances in glycosaminoglycan detection. Mol Genet Metab. 2020 06; 130(2):101-109. PMID: 32247585.
      Citations:    
    45. Oguni T, Tomatsu S, Tanaka M, Orii K, Fukao T, Watanabe J, Fukuda S, Notsu Y, Vu DC, Can TBN, Nagai A, Yamaguchi S, Taketani T, Gelb MH, Kobayashi H. Validation of Liquid Chromatography-Tandem Mass Spectrometry-Based 5-Plex Assay for Mucopolysaccharidoses. Int J Mol Sci. 2020 Mar 16; 21(6). PMID: 32188102.
      Citations:    
    46. Sosa AC, Kariuki B, Gan Q, Knutsen AP, Bellone CJ, Guzm?n MA, Barrera LA, Tomatsu S, Chauhan AK, Armbrecht E, Monta?o AM. Oral immunotherapy tolerizes mice to enzyme replacement therapy for Morquio A syndrome. J Clin Invest. 2020 03 02; 130(3):1288-1300. PMID: 31743109.
      Citations:    
    47. Sawamoto K, ?lvarez Gonz?lez JV, Piechnik M, Otero FJ, Couce ML, Suzuki Y, Tomatsu S. Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management. Int J Mol Sci. 2020 Feb 23; 21(4). PMID: 32102177.
      Citations:    
    48. Orii K, Suzuki Y, Tomatsu S, Orii T, Fukao T. Long-Term Follow-up Posthematopoietic Stem Cell Transplantation in a Japanese Patient with Type-VII Mucopolysaccharidosis. Diagnostics (Basel). 2020 Feb 16; 10(2). PMID: 32079065.
      Citations:    
    49. Langan TJ, Jalal K, Barczykowski AL, Carter RL, Stapleton M, Orii K, Fukao T, Kobayashi H, Yamaguchi S, Tomatsu S. Development of a newborn screening tool for mucopolysaccharidosis type I based on bivariate normal limits: Using glycosaminoglycan and alpha-L-iduronidase determinations on dried blood spots to predict symptoms. JIMD Rep. 2020 Mar; 52(1):35-42. PMID: 32154058.
      Citations:    
    50. Viana GM, Priestman DA, Platt FM, Khan S, Tomatsu S, Pshezhetsky AV. Brain Pathology in Mucopolysaccharidoses (MPS) Patients with Neurological Forms. J Clin Med. 2020 Feb 01; 9(2). PMID: 32024172.
      Citations:    
    51. Suzuki Y, Taylor M, Orii K, Fukao T, Orii T, Tomatsu S. Assessment of Activity of Daily Life in Mucopolysaccharidosis Type II Patients with Hematopoietic Stem Cell Transplantation. Diagnostics (Basel). 2020 Jan 16; 10(1). PMID: 31963134.
      Citations:    
    52. Stapleton M, Kubaski F, Mason RW, Shintaku H, Kobayashi H, Yamaguchi S, Taketani T, Suzuki Y, Orii K, Orii T, Fukao T, Tomatsu S. Newborn screening for mucopolysaccharidoses: Measurement of glycosaminoglycans by LC-MS/MS. Mol Genet Metab Rep. 2020 Mar; 22:100563. PMID: 31956510.
      Citations:    
    53. Orii K, Lim A, Tomatsu S, Stapleton M, Suzuki Y, Simonaro CM, Schuchman EH, Fukao T, Matsumoto T. Safety Study of Sodium Pentosan Polysulfate for Adult Patients with Mucopolysaccharidosis Type II. Diagnostics (Basel). 2019 Dec 17; 9(4). PMID: 31861164.
      Citations:    
    54. Zhang W, Kassels AC, Barrington A, Khan S, Tomatsu S, Alkadi T, Aldave A. Macular corneal dystrophy with isolated peripheral Descemet membrane deposits. Am J Ophthalmol Case Rep. 2019 Dec; 16:100571. PMID: 31799478.
      Citations:    
    55. ?lvarez JV, Herrero Filgueira C, Gonz?lez AF, Col?n Mejeras C, Beiras Iglesias A, Tomatsu S, Blanco M?ndez J, Luzardo ?lvarez A, Couce ML, Otero Espinar FJ. Enzyme-Loaded Gel Core Nanostructured Lipid Carriers to Improve Treatment of Lysosomal Storage Diseases: Formulation and In Vitro Cellular Studies of Elosulfase Alfa-Loaded Systems. Pharmaceutics. 2019 Oct 11; 11(10). PMID: 31614479.
      Citations:    
    56. ?lvarez JV, Bravo SB, Garc?a-Vence M, De Castro MJ, Luzardo A, Col?n C, Tomatsu S, Otero-Espinar FJ, Couce ML. Proteomic Analysis in Morquio A Cells Treated with Immobilized Enzymatic Replacement Therapy on Nanostructured Lipid Systems. Int J Mol Sci. 2019 Sep 18; 20(18). PMID: 31540344.
      Citations:    
    57. Gomez-Ospina N, Scharenberg SG, Mostrel N, Bak RO, Mantri S, Quadros RM, Gurumurthy CB, Lee C, Bao G, Suarez CJ, Khan S, Sawamoto K, Tomatsu S, Raj N, Attardi LD, Aurelian L, Porteus MH. Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I. Nat Commun. 2019 09 06; 10(1):4045. PMID: 31492863.
      Citations:    
    58. Nagao K, Walter C, Parkes WJ, Teixido M, Theroux MC, Szymkowski S, Morlet T, Tomatsu S. Cochlear implantation in a patient with mucopolysaccharidosis IVA. SAGE Open Med Case Rep. 2019; 7:2050313X19873791. PMID: 31516706.
      Citations:    
    59. Chen HH, Sawamoto K, Mason RW, Kobayashi H, Yamaguchi S, Suzuki Y, Orii K, Orii T, Tomatsu S. Enzyme replacement therapy for mucopolysaccharidoses; past, present, and future. J Hum Genet. 2019 Nov; 64(11):1153-1171. PMID: 31455839.
      Citations:    
    60. Sawamoto K, Tomatsu S. Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model. Int J Mol Sci. 2019 Aug 24; 20(17). PMID: 31450640.
      Citations:    
    61. Sawamoto K, Stapleton M, Alm?ciga-D?az CJ, Espejo-Mojica AJ, Losada JC, Suarez DA, Tomatsu S. Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments. Drugs. 2019 Jul; 79(10):1103-1134. PMID: 31209777.
      Citations:    
    62. Doherty C, Stapleton M, Piechnik M, Mason RW, Mackenzie WG, Yamaguchi S, Kobayashi H, Suzuki Y, Tomatsu S. Effect of enzyme replacement therapy on the growth of patients with Morquio A. J Hum Genet. 2019 Jul; 64(7):625-635. PMID: 31019230.
      Citations:    
    63. Rodr?guez-L?pez A, Pimentel-Vera LN, Espejo-Mojica AJ, Van Hecke A, Tiels P, Tomatsu S, Callewaert N, Alm?ciga-D?az CJ. Characterization of Human Recombinant N-Acetylgalactosamine-6-Sulfate Sulfatase Produced in Pichia pastoris as Potential Enzyme for Mucopolysaccharidosis IVA Treatment. J Pharm Sci. 2019 08; 108(8):2534-2541. PMID: 30959056.
      Citations:    
    64. Taylor M, Khan S, Stapleton M, Wang J, Chen J, Wynn R, Yabe H, Chinen Y, Boelens JJ, Mason RW, Kubaski F, Horovitz DDG, Barth AL, Serafini M, Bernardo ME, Kobayashi H, Orii KE, Suzuki Y, Orii T, Tomatsu S. Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future. Biol Blood Marrow Transplant. 2019 07; 25(7):e226-e246. PMID: 30772512.
      Citations:    
    65. Fujitsuka H, Sawamoto K, Peracha H, Mason RW, Mackenzie W, Kobayashi H, Yamaguchi S, Suzuki Y, Orii K, Orii T, Fukao T, Tomatsu S. Biomarkers in patients with mucopolysaccharidosis type II and IV. Mol Genet Metab Rep. 2019 Jun; 19:100455. PMID: 30775257.
      Citations:    
    66. Morgan JT, Robbins AK, Mateson AB, Sawamoto K, Tomatsu S, Gray DR, Gleghorn JP, Barthold JS. Regional Variation in Androgen Receptor Expression and Biomechanical Properties May Contribute to Cryptorchidism Susceptibility in the LE/orl Rat. Front Endocrinol (Lausanne). 2018; 9:738. PMID: 30568634.
      Citations:    
    67. Alm?ciga-D?az CJ, Monta?o AM, Barrera LA, Tomatsu S. Tailoring the AAV2 capsid vector for bone-targeting. Pediatr Res. 2018 10; 84(4):545-551. PMID: 30323349.
      Citations:    
    68. Osaki Y, Saito A, Kanemoto S, Kaneko M, Matsuhisa K, Asada R, Masaki T, Orii K, Fukao T, Tomatsu S, Imaizumi K. Shutdown of ER-associated degradation pathway rescues functions of mutant iduronate 2-sulfatase linked to mucopolysaccharidosis type II. Cell Death Dis. 2018 07 24; 9(8):808. PMID: 30042467.
      Citations:    
    69. Stapleton M, Hoshina H, Sawamoto K, Kubaski F, Mason RW, Mackenzie WG, Theroux M, Kobayashi H, Yamaguchi S, Suzuki Y, Fukao T, Tadao O, Ida H, Tomatsu S. Critical review of current MPS guidelines and management. Mol Genet Metab. 2019 03; 126(3):238-245. PMID: 30143438.
      Citations:    
    70. Khan SA, Mason RW, Giugliani R, Orii K, Fukao T, Suzuki Y, Yamaguchi S, Kobayashi H, Orii T, Tomatsu S. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis. Mol Genet Metab. 2018 09; 125(1-2):44-52. PMID: 29779903.
      Citations:    
    71. Peracha H, Sawamoto K, Averill L, Kecskemethy H, Theroux M, Thacker M, Nagao K, Pizarro C, Mackenzie W, Kobayashi H, Yamaguchi S, Suzuki Y, Orii K, Orii T, Fukao T, Tomatsu S. Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA. Mol Genet Metab. 2018 09; 125(1-2):18-37. PMID: 29779902.
      Citations:    
    72. Melbouci M, Mason RW, Suzuki Y, Fukao T, Orii T, Tomatsu S. Growth impairment in mucopolysaccharidoses. Mol Genet Metab. 2018 05; 124(1):1-10. PMID: 29627275.
      Citations:    
    73. Nagao K, Morlet T, Haley E, Padilla J, Nemith J, Mason RW, Tomatsu S. Neurophysiology of hearing in patients with mucopolysaccharidosis type IV. Mol Genet Metab. 2018 04; 123(4):472-478. PMID: 29472067.
      Citations:    
    74. Stapleton M, Arunkumar N, Kubaski F, Mason RW, Tadao O, Tomatsu S. Clinical presentation and diagnosis of mucopolysaccharidoses. Mol Genet Metab. 2018 09; 125(1-2):4-17. PMID: 30057281.
      Citations:    
    75. Sawamoto K, Chen HH, Alm?ciga-D?az CJ, Mason RW, Tomatsu S. Gene therapy for Mucopolysaccharidoses. Mol Genet Metab. 2018 02; 123(2):59-68. PMID: 29295764.
      Citations:    
    76. Doherty C, Averill LW, Theroux M, Mackenzie WG, Pizarro C, Mason RW, Tomatsu S. Natural history of Morquio A patient with tracheal obstruction from birth to death. Mol Genet Metab Rep. 2018 Mar; 14:59-67. PMID: 29326877.
      Citations:    
    77. Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M. Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 08 25; 7(1):9473. PMID: 28842642.
      Citations:    
    78. Kubaski F, Yabe H, Suzuki Y, Seto T, Hamazaki T, Mason RW, Xie L, Onsten TGH, Leistner-Segal S, Giugliani R, Dung VC, Ngoc CTB, Yamaguchi S, Monta?o AM, Orii KE, Fukao T, Shintaku H, Orii T, Tomatsu S. Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II. Biol Blood Marrow Transplant. 2017 Oct; 23(10):1795-1803. PMID: 28673849.
      Citations:    
    79. Stapleton M, Sawamoto K, Alm?ciga-D?az CJ, Mackenzie WG, Mason RW, Orii T, Tomatsu S. Development of Bone Targeting Drugs. Int J Mol Sci. 2017 Jun 23; 18(7). PMID: 28644392.
      Citations:    
    80. Khan SA, Peracha H, Ballhausen D, Wiesbauer A, Rohrbach M, Gautschi M, Mason RW, Giugliani R, Suzuki Y, Orii KE, Orii T, Tomatsu S. Epidemiology of mucopolysaccharidoses. Mol Genet Metab. 2017 07; 121(3):227-240. PMID: 28595941.
      Citations:    
    81. Kubaski F, Brusius-Facchin AC, Mason RW, Patel P, Burin MG, Michelin-Tirelli K, Kessler RG, Bender F, Leistner-Segal S, Moreno CA, Cavalcanti DP, Giugliani R, Tomatsu S. Elevation of glycosaminoglycans in the amniotic fluid of a fetus with mucopolysaccharidosis VII. Prenat Diagn. 2017 May; 37(5):435-439. PMID: 28207930.
      Citations:    
    82. Stapleton M, Kubaski F, Mason RW, Yabe H, Suzuki Y, Orii KE, Orii T, Tomatsu S. Presentation and Treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome). Expert Opin Orphan Drugs. 2017; 5(4):295-307. PMID: 29158997.
      Citations:    
    83. Doherty C, Kubaski F, Tomatsu S, Shaffer TH. Non-invasive pulmonary function test on Morquio patients. J Rare Dis Res Treat. 2017; 2(2):55-62. PMID: 30294725.
      Citations:    
    84. Kubaski F, Suzuki Y, Orii K, Giugliani R, Church HJ, Mason RW, Dung VC, Ngoc CT, Yamaguchi S, Kobayashi H, Girisha KM, Fukao T, Orii T, Tomatsu S. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses. Mol Genet Metab. 2017 03; 120(3):247-254. PMID: 28065440.
      Citations:    
    85. Khan S, Alm?ciga-D?az CJ, Sawamoto K, Mackenzie WG, Theroux MC, Pizarro C, Mason RW, Orii T, Tomatsu S. Mucopolysaccharidosis IVA and glycosaminoglycans. Mol Genet Metab. 2017 Jan - Feb; 120(1-2):78-95. PMID: 27979613.
      Citations:    
    86. Kubaski F, Mason RW, Nakatomi A, Shintaku H, Xie L, van Vlies NN, Church H, Giugliani R, Kobayashi H, Yamaguchi S, Suzuki Y, Orii T, Fukao T, Monta?o AM, Tomatsu S. Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry. J Inherit Metab Dis. 2017 01; 40(1):151-158. PMID: 27718145.
      Citations:    
    87. Pizarro C, Davies RR, Theroux M, Spurrier EA, Averill LW, Tomatsu S. Surgical Reconstruction for Severe Tracheal Obstruction in Morquio A Syndrome. Ann Thorac Surg. 2016 Oct; 102(4):e329-31. PMID: 27645974.
      Citations:    
    88. Kubaski F, Osago H, Mason RW, Yamaguchi S, Kobayashi H, Tsuchiya M, Orii T, Tomatsu S. Glycosaminoglycans detection methods: Applications of mass spectrometry. Mol Genet Metab. 2017 Jan - Feb; 120(1-2):67-77. PMID: 27746032.
      Citations:    
    89. Kubaski F, Kecskemethy HH, Harcke HT, Tomatsu S. Bone mineral density in mucopolysaccharidosis IVB. Mol Genet Metab Rep. 2016 Sep; 8:80-84. PMID: 27699153.
      Citations:    
    90. Sawamoto K, Suzuki Y, Mackenzie WG, Theroux MC, Pizarro C, Yabe H, Orii KE, Mason RW, Orii T, Tomatsu S. Current therapies for Morquio A syndrome and their clinical outcomes. Expert Opin Orphan Drugs. 2016; 4(9):941-951. PMID: 28217429.
      Citations:    
    91. Auray-Blais C, Lavoie P, Tomatsu S, Valayannopoulos V, Mitchell JJ, Raiman J, Beaudoin M, Maranda B, Clarke JT. UPLC-MS/MS detection of disaccharides derived from glycosaminoglycans as biomarkers of mucopolysaccharidoses. Anal Chim Acta. 2016 Sep 14; 936:139-48. PMID: 27566349.
      Citations:    
    92. Yasuda E, Suzuki Y, Shimada T, Sawamoto K, Mackenzie WG, Theroux MC, Pizarro C, Xie L, Miller F, Rahman T, Kecskemethy HH, Nagao K, Morlet T, Shaffer TH, Chinen Y, Yabe H, Tanaka A, Shintaku H, Orii KE, Orii KO, Mason RW, Monta?o AM, Fukao T, Orii T, Tomatsu S. Activity of daily living for Morquio A syndrome. Mol Genet Metab. 2016 06; 118(2):111-22. PMID: 27161890.
      Citations:    
    93. Simonaro CM, Tomatsu S, Sikora T, Kubaski F, Frohbergh M, Guevara JM, Wang RY, Vera M, Kang JL, Smith LJ, Schuchman EH, Haskins ME. Pentosan Polysulfate: Oral Versus Subcutaneous Injection in Mucopolysaccharidosis Type I Dogs. PLoS One. 2016; 11(4):e0153136. PMID: 27064989.
      Citations:    
    94. Kecskemethy HH, Kubaski F, Harcke HT, Tomatsu S. Bone mineral density in MPS IV A (Morquio syndrome type A). Mol Genet Metab. 2016 Feb; 117(2):144-9. PMID: 26670863.
      Citations:    
    95. Tomatsu S, Azario I, Sawamoto K, Pievani AS, Biondi A, Serafini M. Neonatal cellular and gene therapies for mucopolysaccharidoses: the earlier the better? J Inherit Metab Dis. 2016 Mar; 39(2):189-202. PMID: 26578156.
      Citations:    
    96. Tomatsu S, Sawamoto K, Shimada T, Bober MB, Kubaski F, Yasuda E, Mason RW, Khan S, Alm?ciga-D?az CJ, Barrera LA, Mackenzie WG, Orii T. Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations. Expert Opin Orphan Drugs. 2015 Nov 01; 3(11):1279-1290. PMID: 26973801.
      Citations:    
    97. Yabe H, Tanaka A, Chinen Y, Kato S, Sawamoto K, Yasuda E, Shintaku H, Suzuki Y, Orii T, Tomatsu S. Hematopoietic stem cell transplantation for Morquio A syndrome. Mol Genet Metab. 2016 Feb; 117(2):84-94. PMID: 26452513.
      Citations:    
    98. Tomatsu S, Averill LW, Sawamoto K, Mackenzie WG, Bober MB, Pizarro C, Goff CJ, Xie L, Orii T, Theroux M. Obstructive airway in Morquio A syndrome, the past, the present and the future. Mol Genet Metab. 2016 Feb; 117(2):150-6. PMID: 26432669.
      Citations:    
    99. Kubaski F, Tomatsu S, Patel P, Shimada T, Xie L, Yasuda E, Mason R, Mackenzie WG, Theroux M, Bober MB, Oldham HM, Orii T, Shaffer TH. Non-invasive pulmonary function test on Morquio patients. Mol Genet Metab. 2015 Aug; 115(4):186-92. PMID: 26116954.
      Citations:    
    100. Tomatsu S, Sawamoto K, Alm?ciga-D?az CJ, Shimada T, Bober MB, Chinen Y, Yabe H, Monta?o AM, Giugliani R, Kubaski F, Yasuda E, Rodr?guez-L?pez A, Espejo-Mojica AJ, S?nchez OF, Mason RW, Barrera LA, Mackenzie WG, Orii T. Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome. Drug Des Devel Ther. 2015; 9:1937-53. PMID: 25897204.
      Citations:    
    101. Yasuda E, Mackenzie W, Ruhnke K, Shimada T, Mason RW, Zustin J, Martin PL, Thacker M, Orii T, Sai Y, Tomatsu S. Molecular Genetics and Metabolism Report Long-term follow-up of post hematopoietic stem cell transplantation for Hurler syndrome: clinical, biochemical, and pathological improvements. Mol Genet Metab Rep. 2015 Mar; 2:65-76. PMID: 25709894.
      Citations:    
    102. Shimada T, Tomatsu S, Mason RW, Yasuda E, Mackenzie WG, Hossain J, Shibata Y, Monta?o AM, Kubaski F, Giugliani R, Yamaguchi S, Suzuki Y, Orii KE, Fukao T, Orii T. Di-sulfated Keratan Sulfate as a Novel Biomarker for Mucopolysaccharidosis II, IVA, and IVB. JIMD Rep. 2015; 21:1-13. PMID: 25712379.
      Citations:    
    103. Tomatsu S, Alm?ciga-D?az CJ, Monta?o AM, Yabe H, Tanaka A, Dung VC, Giugliani R, Kubaski F, Mason RW, Yasuda E, Sawamoto K, Mackenzie W, Suzuki Y, Orii KE, Barrera LA, Sly WS, Orii T. Therapies for the bone in mucopolysaccharidoses. Mol Genet Metab. 2015 Feb; 114(2):94-109. PMID: 25537451.
      Citations:    
    104. Tanjuakio J, Suzuki Y, Patel P, Yasuda E, Kubaski F, Tanaka A, Yabe H, Mason RW, Monta?o AM, Orii KE, Orii KO, Fukao T, Orii T, Tomatsu S. Activities of daily living in patients with Hunter syndrome: impact of enzyme replacement therapy and hematopoietic stem cell transplantation. Mol Genet Metab. 2015 Feb; 114(2):161-9. PMID: 25468646.
      Citations:    
    105. Drummond JC, Krane EJ, Tomatsu S, Theroux MC, Lee RR. Paraplegia after epidural-general anesthesia in a Morquio patient with moderate thoracic spinal stenosis. Can J Anaesth. 2015 Jan; 62(1):45-9. PMID: 25323122.
      Citations:    
    106. Pievani A, Azario I, Antolini L, Shimada T, Patel P, Remoli C, Rambaldi B, Valsecchi MG, Riminucci M, Biondi A, Tomatsu S, Serafini M. Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I. Blood. 2015 Mar 05; 125(10):1662-71. PMID: 25298037.
      Citations:    
    107. Tomatsu S, Yasuda E, Patel P, Ruhnke K, Shimada T, Mackenzie WG, Mason R, Thacker MM, Theroux M, Monta?o AM, Alm?ciga-D?az CJ, Barrera LA, Chinen Y, Sly WS, Rowan D, Suzuki Y, Orii T. Morquio A syndrome: diagnosis and current and future therapies. Pediatr Endocrinol Rev. 2014 Sep; 12 Suppl 1:141-51. PMID: 25345096.
      Citations:    
    108. Tomatsu S, Shimada T, Mason RW, Monta?o AM, Kelly J, LaMarr WA, Kubaski F, Giugliani R, Guha A, Yasuda E, Mackenzie W, Yamaguchi S, Suzuki Y, Orii T. Establishment of glycosaminoglycan assays for mucopolysaccharidoses. Metabolites. 2014 Aug 11; 4(3):655-79. PMID: 25116756.
      Citations:    
    109. Shimada T, Kelly J, LaMarr WA, van Vlies N, Yasuda E, Mason RW, Mackenzie W, Kubaski F, Giugliani R, Chinen Y, Yamaguchi S, Suzuki Y, Orii KE, Fukao T, Orii T, Tomatsu S. Novel heparan sulfate assay by using automated high-throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses. Mol Genet Metab. 2014 Sep-Oct; 113(1-2):92-9. PMID: 25092413.
      Citations:    
    110. Tomatsu S, Monta?o AM, Oikawa H, Dung VC, Hashimoto A, Oguma T, Guti?rrez ML, Takahashi T, Shimada T, Orii T, Sly WS. Enzyme replacement therapy in newborn mucopolysaccharidosis IVA mice: early treatment rescues bone lesions? Mol Genet Metab. 2015 Feb; 114(2):195-202. PMID: 24953405.
      Citations:    
    111. Shimada T, Tomatsu S, Yasuda E, Mason RW, Mackenzie WG, Shibata Y, Kubaski F, Giugliani R, Yamaguchi S, Suzuki Y, Orii K, Orii T. Chondroitin 6-Sulfate as a Novel Biomarker for Mucopolysaccharidosis IVA and VII. JIMD Rep. 2014; 16:15-24. PMID: 24850234.
      Citations:    
    112. Shimada T, Nakayama Y, Harasawa Y, Matsui H, Kobayashi H, Sai Y, Miyamoto K, Tomatsu S, Aburada M. Salacia reticulata has therapeutic effects on obesity. J Nat Med. 2014 Oct; 68(4):668-76. PMID: 24838513.
      Citations:    
    113. Tomatsu S, Shimada T, Mason RW, Kelly J, LaMarr WA, Yasuda E, Shibata Y, Futatsumori H, Monta?o AM, Yamaguchi S, Suzuki Y, Orii T. Assay for Glycosaminoglycans by Tandem Mass Spectrometry and its Applications. J Anal Bioanal Tech. 2014 Mar 01; 2014(Suppl 2):006. PMID: 25068074.
      Citations:    
    114. Patel P, Suzuki Y, Tanaka A, Yabe H, Kato S, Shimada T, Mason RW, Orii KE, Fukao T, Orii T, Tomatsu S. Impact of Enzyme Replacement Therapy and Hematopoietic Stem Cell Therapy on Growth in Patients with Hunter Syndrome. Mol Genet Metab Rep. 2014; 1:184-196. PMID: 25061571.
      Citations:    
    115. Patel P, Suzuki Y, Maeda M, Yasuda E, Shimada T, Orii KE, Orii T, Tomatsu S. Growth charts for patients with Hunter syndrome. Mol Genet Metab Rep. 2014; 1:5-18. PMID: 24955330.
      Citations:    
    116. Tomatsu S, Kubaski F, Sawamoto K, Mason RW, Yasuda E, Shimada T, Monta?o AM, Yamaguchi S, Suzuki Y, Orii T. Newborn screening and diagnosis of mucopolysaccharidoses: application of tandem mass spectrometry. Nihon Masu Sukuriningu Gakkai Shi. 2014; 24:19-37. PMID: 25620850.
      Citations:    
    117. Chinen Y, Higa T, Tomatsu S, Suzuki Y, Orii T, Hyakuna N. Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA. Mol Genet Metab Rep. 2014; 1:31-41. PMID: 25593792.
      Citations:    
    118. Tomatsu S, Alm?ciga-D?az CJ, Barbosa H, Monta?o AM, Barrera LA, Shimada T, Yasuda E, Mackenzie WG, Mason RW, Suzuki Y, Orii KE, Orii T. Therapies of mucopolysaccharidosis IVA (Morquio A syndrome). Expert Opin Orphan Drugs. 2013 Oct 01; 1(10):805-818. PMID: 25419501.
      Citations:    
    119. Oikawa H, Tomatsu S, Haupt B, Monta?o AM, Shimada T, Sly WS. Enzyme replacement therapy on hypophosphatasia mouse model. J Inherit Metab Dis. 2014 Mar; 37(2):309-317. PMID: 23978959.
      Citations:    
    120. Takahashi T, Katsuta S, Tamura Y, Nagase N, Suzuki K, Nomura M, Tomatsu S, Miyamoto K, Kobayashi S. Bone-targeting endogenous secretory receptor for advanced glycation end products rescues rheumatoid arthritis. Mol Med. 2013 Jul 24; 19:183-94. PMID: 23821362.
      Citations:    
    121. Dung VC, Tomatsu S, Monta?o AM, Gottesman G, Bober MB, Mackenzie W, Maeda M, Mitchell GA, Suzuki Y, Orii T. Mucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels. Mol Genet Metab. 2013 Sep-Oct; 110(1-2):129-38. PMID: 23876334.
      Citations:    
    122. Tomatsu S, Fujii T, Fukushi M, Oguma T, Shimada T, Maeda M, Kida K, Shibata Y, Futatsumori H, Monta?o AM, Mason RW, Yamaguchi S, Suzuki Y, Orii T. Newborn screening and diagnosis of mucopolysaccharidoses. Mol Genet Metab. 2013 Sep-Oct; 110(1-2):42-53. PMID: 23860310.
      Citations:    
    123. Yasuda E, Fushimi K, Suzuki Y, Shimizu K, Takami T, Zustin J, Patel P, Ruhnke K, Shimada T, Boyce B, Kokas T, Barone C, Theroux M, Mackenzie W, Nagel B, Ryerse JS, Orii KE, Iida H, Orii T, Tomatsu S. Pathogenesis of Morquio A syndrome: an autopsied case reveals systemic storage disorder. Mol Genet Metab. 2013 Jul; 109(3):301-11. PMID: 23683769.
      Citations:    
    124. Hendriksz CJ, Harmatz P, Beck M, Jones S, Wood T, Lachman R, Gravance CG, Orii T, Tomatsu S. Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA. Mol Genet Metab. 2013 Sep-Oct; 110(1-2):54-64. PMID: 23665161.
      Citations:    
    125. Tomatsu S, Mackenzie WG, Theroux MC, Mason RW, Thacker MM, Shaffer TH, Monta?o AM, Rowan D, Sly W, Alm?ciga-D?az CJ, Barrera LA, Chinen Y, Yasuda E, Ruhnke K, Suzuki Y, Orii T. Current and emerging treatments and surgical interventions for Morquio A syndrome: a review. Res Rep Endocr Disord. 2012 Dec; 2012(2):65-77. PMID: 24839594.
      Citations:    
    126. Rowan DJ, Tomatsu S, Grubb JH, Monta?o AM, Sly WS. Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII. J Inherit Metab Dis. 2013 Mar; 36(2):235-46. PMID: 22971960.
      Citations:    
    127. Rowan DJ, Tomatsu S, Grubb JH, Haupt B, Monta?o AM, Oikawa H, Sosa AC, Chen A, Sly WS. Long circulating enzyme replacement therapy rescues bone pathology in mucopolysaccharidosis VII murine model. Mol Genet Metab. 2012 Sep; 107(1-2):161-72. PMID: 22902520.
      Citations:    
    128. Hintze JP, Tomatsu S, Fujii T, Monta?o AM, Yamaguchi S, Suzuki Y, Fukushi M, Ishimaru T, Orii T. Comparison of liquid chromatography-tandem mass spectrometry and sandwich ELISA for determination of keratan sulfate in plasma and urine. Biomark Insights. 2011; 6:69-78. PMID: 21792275.
      Citations:    
    129. Tomatsu S, Monta?o AM, Oikawa H, Smith M, Barrera L, Chinen Y, Thacker MM, Mackenzie WG, Suzuki Y, Orii T. Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment. Curr Pharm Biotechnol. 2011 Jun; 12(6):931-45. PMID: 21506915.
      Citations:    
    130. Alm?ciga-D?az CJ, Monta?o AM, Tomatsu S, Barrera LA. Adeno-associated virus gene transfer in Morquio A disease - effect of promoters and sulfatase-modifying factor 1. FEBS J. 2010 Sep; 277(17):3608-19. PMID: 20716181.
      Citations:    
    131. Tomatsu S, Monta?o AM, Dung VC, Ohashi A, Oikawa H, Oguma T, Orii T, Barrera L, Sly WS. Enhancement of drug delivery: enzyme-replacement therapy for murine Morquio A syndrome. Mol Ther. 2010 Jun; 18(6):1094-102. PMID: 20332769.
      Citations:    
    132. Tomatsu S, Monta?o AM, Oguma T, Dung VC, Oikawa H, de Carvalho TG, Guti?rrez ML, Yamaguchi S, Suzuki Y, Fukushi M, Sakura N, Barrera L, Kida K, Kubota M, Orii T. Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I. J Inherit Metab Dis. 2010 Apr; 33(2):141-50. PMID: 20162367.
      Citations:    
    133. Tomatsu S, Monta?o AM, Oguma T, Dung VC, Oikawa H, de Carvalho TG, Guti?rrez ML, Yamaguchi S, Suzuki Y, Fukushi M, Kida K, Kubota M, Barrera L, Orii T. Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry. J Inherit Metab Dis. 2010 Dec; 33 Suppl 3:S35-42. PMID: 20107903.
      Citations:    
    134. Tomatsu S, Monta?o AM, Oguma T, Dung VC, Oikawa H, Guti?rrez ML, Yamaguchi S, Suzuki Y, Fukushi M, Barrera LA, Kida K, Kubota M, Orii T. Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry. Mol Genet Metab. 2010 Feb; 99(2):124-31. PMID: 19932038.
      Citations:    
    135. Ohashi A, Monta?o AM, Col?n JE, Oguma T, Luisiri A, Tomatsu S. Sacral dimple: incidental findings from newborn evaluation. Mucopolysaccharidosis IVA disease. Acta Paediatr. 2009 May; 98(5):768-9, 910-2. PMID: 19389117.
      Citations:    
    136. Tomatsu S, Monta?o AM, Dung VC, Grubb JH, Sly WS. Mutations and polymorphisms in GUSB gene in mucopolysaccharidosis VII (Sly Syndrome). Hum Mutat. 2009 Apr; 30(4):511-9. PMID: 19224584.
      Citations:    
    137. Alm?ciga-D?az CJ, Rueda-Paramo MA, Espejo AJ, Echeverri OY, Monta?o A, Tomatsu S, Barrera LA. Effect of elongation factor 1alpha promoter and SUMF1 over in vitro expression of N-acetylgalactosamine-6-sulfate sulfatase. Mol Biol Rep. 2009 Sep; 36(7):1863-70. PMID: 18989752.
      Citations:    
    138. Guti?rrez MA, Garc?a-Vallejo F, Tomatsu S, Cer?n F, Alm?ciga-D?az CJ, Dom?nguez MC, Barrera LA. [Construction of an adenoassociated, viral derived, expression vector to correct the genetic defect in Morquio A disease]. Biomedica. 2008 Sep; 28(3):448-59. PMID: 19034368.
      Citations:    
    139. Carraresi L, Parini R, Filoni C, Caciotti A, Sersale G, Tomatsu S, Orlando C, Zammarchi E, Guerrini R, Donati MA, Morrone A. GALNS gene expression profiling in Morquio A patients' fibroblasts. Clin Chim Acta. 2008 Nov; 397(1-2):72-6. PMID: 18710657.
      Citations:    
    140. Monta?o AM, Tomatsu S, Brusius A, Smith M, Orii T. Growth charts for patients affected with Morquio A disease. Am J Med Genet A. 2008 May 15; 146A(10):1286-95. PMID: 18412124.
      Citations:    
    141. Monta?o AM, Oikawa H, Tomatsu S, Nishioka T, Vogler C, Gutierrez MA, Oguma T, Tan Y, Grubb JH, Dung VC, Ohashi A, Miyamoto K, Orii T, Yoneda Y, Sly WS. Acidic amino acid tag enhances response to enzyme replacement in mucopolysaccharidosis type VII mice. Mol Genet Metab. 2008 Jun; 94(2):178-89. PMID: 18359257.
      Citations:    
    142. Takahashi-Nishioka T, Yokogawa K, Tomatsu S, Nomura M, Kobayashi S, Miyamoto K. Targeted drug delivery to bone: pharmacokinetic and pharmacological properties of acidic oligopeptide-tagged drugs. Curr Drug Discov Technol. 2008 Mar; 5(1):39-48. PMID: 18537566.
      Citations:    
    143. Tomatsu S, Monta?o AM, Ohashi A, Gutierrez MA, Oikawa H, Oguma T, Dung VC, Nishioka T, Orii T, Sly WS. Enzyme replacement therapy in a murine model of Morquio A syndrome. Hum Mol Genet. 2008 Mar 15; 17(6):815-24. PMID: 18056156.
      Citations:    
    144. Monta?o AM, Sukegawa K, Kato Z, Carrozzo R, Di Natale P, Christensen E, Orii KO, Orii T, Kondo N, Tomatsu S. Effect of 'attenuated' mutations in mucopolysaccharidosis IVA on molecular phenotypes of N-acetylgalactosamine-6-sulfate sulfatase. J Inherit Metab Dis. 2007 Oct; 30(5):758-67. PMID: 17876718.
      Citations:    
    145. Oguma T, Tomatsu S, Montano AM, Okazaki O. Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography/turbo ionspray ionization tandem mass spectrometry. Anal Biochem. 2007 Sep 01; 368(1):79-86. PMID: 17603992.
      Citations:    
    146. Tomatsu S, Vogler C, Monta?o AM, Gutierrez M, Oikawa H, Dung VC, Orii T, Noguchi A, Sly WS. Murine model (Galns(tm(C76S)slu)) of MPS IVA with missense mutation at the active site cysteine conserved among sulfatase proteins. Mol Genet Metab. 2007 Jul; 91(3):251-8. PMID: 17498992.
      Citations:    
    147. Oguma T, Tomatsu S, Okazaki O. Analytical method for determination of disaccharides derived from keratan sulfates in human serum and plasma by high-performance liquid chromatography/turbo-ionspray ionization tandem mass spectrometry. Biomed Chromatogr. 2007 Apr; 21(4):356-62. PMID: 17236248.
      Citations:    
    148. Monta?o AM, Tomatsu S, Gottesman GS, Smith M, Orii T. International Morquio A Registry: clinical manifestation and natural course of Morquio A disease. J Inherit Metab Dis. 2007 Apr; 30(2):165-74. PMID: 17347914.
      Citations:    
    149. Tomatsu S, Monta?o AM, Gutierrez M, Grubb JH, Oikawa H, Dung VC, Ohashi A, Nishioka T, Yamada M, Yamada M, Tosaka Y, Trandafirescu GG, Orii T. Characterization and pharmacokinetic study of recombinant human N-acetylgalactosamine-6-sulfate sulfatase. Mol Genet Metab. 2007 May; 91(1):69-78. PMID: 17336563.
      Citations:    
    150. Sukegawa-Hayasaka K, Kato Z, Nakamura H, Tomatsu S, Fukao T, Kuwata K, Orii T, Kondo N. Effect of Hunter disease (mucopolysaccharidosis type II) mutations on molecular phenotypes of iduronate-2-sulfatase: enzymatic activity, protein processing and structural analysis. J Inherit Metab Dis. 2006 Dec; 29(6):755-61. PMID: 17091340.
      Citations:    
    151. Sly WS, Vogler C, Grubb JH, Levy B, Galvin N, Tan Y, Nishioka T, Tomatsu S. Enzyme therapy in mannose receptor-null mucopolysaccharidosis VII mice defines roles for the mannose 6-phosphate and mannose receptors. Proc Natl Acad Sci U S A. 2006 Oct 10; 103(41):15172-7. PMID: 17015822.
      Citations:    
    152. Tomatsu S, Monta?o AM, Lopez P, Trandafirescu G, Gutierrez MA, Oikawa H, Nishioka T, Vieira MB, Orii T, Noguchi A. Determinant factors of spectrum of missense variants in mucopolysaccharidosis IVA gene. Mol Genet Metab. 2006 Sep-Oct; 89(1-2):139-49. PMID: 16837223.
      Citations:    
    153. Nishioka T, Tomatsu S, Gutierrez MA, Miyamoto K, Trandafirescu GG, Lopez PL, Grubb JH, Kanai R, Kobayashi H, Yamaguchi S, Gottesman GS, Cahill R, Noguchi A, Sly WS. Enhancement of drug delivery to bone: characterization of human tissue-nonspecific alkaline phosphatase tagged with an acidic oligopeptide. Mol Genet Metab. 2006 Jul; 88(3):244-55. PMID: 16616566.
      Citations:    
    154. Tomatsu S, Sukegawa K, Trandafirescu GG, Gutierrez MA, Nishioka T, Yamaguchi S, Orii T, Froissart R, Maire I, Chabas A, Cooper A, Di Natale P, Gal A, Noguchi A, Sly WS. Differences in methylation patterns in the methylation boundary region of IDS gene in Hunter syndrome patients: implications for CpG hot spot mutations. Eur J Hum Genet. 2006 Jul; 14(7):838-45. PMID: 16617305.
      Citations:    
    155. Tomatsu S, Monta?o AM, Nishioka T, Gutierrez MA, Pe?a OM, Tranda Firescu GG, Lopez P, Yamaguchi S, Noguchi A, Orii T. Mutation and polymorphism spectrum of the GALNS gene in mucopolysaccharidosis IVA (Morquio A). Hum Mutat. 2005 Dec; 26(6):500-12. PMID: 16287098.
      Citations:    
    156. Tomatsu S, Gutierrez M, Nishioka T, Yamada M, Yamada M, Tosaka Y, Grubb JH, Monta?o AM, Vieira MB, Trandafirescu GG, Pe?a OM, Yamaguchi S, Orii KO, Orii T, Noguchi A, Laybauer L. Development of MPS IVA mouse (Galnstm(hC79S.mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase. Hum Mol Genet. 2005 Nov 15; 14(22):3321-35. PMID: 16219627.
      Citations:    
    157. Tomatsu S, Gutierrez MA, Ishimaru T, Pe?a OM, Monta?o AM, Maeda H, Velez-Castrillon S, Nishioka T, Fachel AA, Cooper A, Thornley M, Wraith E, Barrera LA, Laybauer LS, Giugliani R, Schwartz IV, Frenking GS, Beck M, Kircher SG, Paschke E, Yamaguchi S, Ullrich K, Isogai K, Suzuki Y, Orii T, Noguchi A. Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses. J Inherit Metab Dis. 2005; 28(5):743-57. PMID: 16151906.
      Citations:    
    158. Tomatsu S, Okamura K, Maeda H, Taketani T, Castrillon SV, Gutierrez MA, Nishioka T, Fachel AA, Orii KO, Grubb JH, Cooper A, Thornley M, Wraith E, Barrera LA, Laybauer LS, Giugliani R, Schwartz IV, Frenking GS, Beck M, Kircher SG, Paschke E, Yamaguchi S, Ullrich K, Haskins M, Isogai K, Suzuki Y, Orii T, Kondo N, Creer M, Okuyama T, Tanaka A, Noguchi A. Keratan sulphate levels in mucopolysaccharidoses and mucolipidoses. J Inherit Metab Dis. 2005; 28(2):187-202. PMID: 15877208.
      Citations:    
    159. Tomatsu S, Dieter T, Schwartz IV, Sarmient P, Giugliani R, Barrera LA, Guelbert N, Kremer R, Repetto GM, Gutierrez MA, Nishioka T, Serrato OP, Monta?o AM, Yamaguchi S, Noguchi A. Identification of a common mutation in mucopolysaccharidosis IVA: correlation among genotype, phenotype, and keratan sulfate. J Hum Genet. 2004; 49(9):490-494. PMID: 15309681.
      Citations:    
    160. Tomatsu S, Filocamo M, Orii KO, Sly WS, Gutierrez MA, Nishioka T, Serrato OP, Di Natale P, Monta?o AM, Yamaguchi S, Kondo N, Orii T, Noguchi A. Mucopolysaccharidosis IVA (Morquio A): identification of novel common mutations in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene in Italian patients. Hum Mutat. 2004 Aug; 24(2):187-8. PMID: 15241807.
      Citations:    
    161. Tomatsu S, Nishioka T, Monta?o AM, Gutierrez MA, Pena OS, Orii KO, Sly WS, Yamaguchi S, Orii T, Paschke E, Kircher SG, Noguchi A. Mucopolysaccharidosis IVA: identification of mutations and methylation study in GALNS gene. J Med Genet. 2004 Jul; 41(7):e98. PMID: 15235041.
      Citations:    
    162. Tomatsu S, Orii KO, Bi Y, Gutierrez MA, Nishioka T, Yamaguchi S, Kondo N, Orii T, Noguchi A, Sly WS. General implications for CpG hot spot mutations: methylation patterns of the human iduronate-2-sulfatase gene locus. Hum Mutat. 2004 Jun; 23(6):590-8. PMID: 15146464.
      Citations:    
    163. Tomatsu S, Okamura K, Taketani T, Orii KO, Nishioka T, Gutierrez MA, Velez-Castrillon S, Fachel AA, Grubb JH, Cooper A, Thornley M, Wraith E, Barrera LA, Giugliani R, Schwartz IV, Frenking GS, Beck M, Kircher SG, Paschke E, Yamaguchi S, Ullrich K, Isogai K, Suzuki Y, Orii T, Kondo N, Creer M, Noguchi A. Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA. Pediatr Res. 2004 Apr; 55(4):592-7. PMID: 14711889.
      Citations:    
    164. Tomatsu S, Orii KO, Fleming RE, Holden CC, Waheed A, Britton RS, Gutierrez MA, Velez-Castrillon S, Bacon BR, Sly WS. Contribution of the H63D mutation in HFE to murine hereditary hemochromatosis. Proc Natl Acad Sci U S A. 2003 Dec 23; 100(26):15788-93. PMID: 14673107; PMCID: PMC307646.
      Citations:    
    165. Tomatsu S, Orii KO, Vogler C, Nakayama J, Levy B, Grubb JH, Gutierrez MA, Shim S, Yamaguchi S, Nishioka T, Montano AM, Noguchi A, Orii T, Kondo N, Sly WS. Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-/-) produced by targeted disruption of the gene defective in Morquio A disease. Hum Mol Genet. 2003 Dec 15; 12(24):3349-58. PMID: 14583446.
      Citations:    
    166. Tomatsu S, Orii KO, Vogler C, Grubb JH, Snella EM, Gutierrez M, Dieter T, Holden CC, Sukegawa K, Orii T, Kondo N, Sly WS. Production of MPS VII mouse (Gus(tm(hE540A x mE536A)Sly)) doubly tolerant to human and mouse beta-glucuronidase. Hum Mol Genet. 2003 May 01; 12(9):961-73. PMID: 12700165.
      Citations:    
    167. Monta?o AM, Kaitila I, Sukegawa K, Tomatsu S, Kato Z, Nakamura H, Fukuda S, Orii T, Kondo N. Mucopolysaccharidosis IVA: characterization of a common mutation found in Finnish patients with attenuated phenotype. Hum Genet. 2003 Jul; 113(2):162-9. PMID: 12721840.
      Citations:    
    168. Tomatsu S, Orii KO, Vogler C, Grubb JH, Snella EM, Gutierrez MA, Dieter T, Sukegawa K, Orii T, Kondo N, Sly WS. Missense models [Gustm(E536A)Sly, Gustm(E536Q)Sly, and Gustm(L175F)Sly] of murine mucopolysaccharidosis type VII produced by targeted mutagenesis. Proc Natl Acad Sci U S A. 2002 Nov 12; 99(23):14982-7. PMID: 12403825.
      Citations:    
    169. Tomatsu S, Orii KO, Islam MR, Shah GN, Grubb JH, Sukegawa K, Suzuki Y, Orii T, Kondo N, Sly WS. Methylation patterns of the human beta-glucuronidase gene locus: boundaries of methylation and general implications for frequent point mutations at CpG dinucleotides. Genomics. 2002 Mar; 79(3):363-75. PMID: 11863366.
      Citations:    
    170. Waheed A, Grubb JH, Zhou XY, Tomatsu S, Fleming RE, Costaldi ME, Britton RS, Bacon BR, Sly WS. Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci U S A. 2002 Mar 05; 99(5):3117-22. PMID: 11867720; PMCID: PMC122482.
      Citations:    
    171. Toietta G, Severini GM, Traversari C, Tomatsu S, Sukegawa K, Fukuda S, Kondo N, Tortora P, Bordignon C. Various cells retrovirally transduced with N-acetylgalactosoamine-6-sulfate sulfatase correct Morquio skin fibroblasts in vitro. Hum Gene Ther. 2001 Nov 01; 12(16):2007-16. PMID: 11686941.
      Citations:    
    172. Takahashi Y, Sukegawa K, Aoki M, Ito A, Suzuki K, Sakaguchi H, Watanabe M, Isogai K, Mizuno S, Hoshi H, Kuwata K, Tomatsu S, Kato S, Ito T, Kondo N, Orii T. Evaluation of accumulated mucopolysaccharides in the brain of patients with mucopolysaccharidoses by (1)H-magnetic resonance spectroscopy before and after bone marrow transplantation. Pediatr Res. 2001 Mar; 49(3):349-55. PMID: 11228260.
      Citations:    
    173. Fleming RE, Holden CC, Tomatsu S, Waheed A, Brunt EM, Britton RS, Bacon BR, Roopenian DC, Sly WS. Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis. Proc Natl Acad Sci U S A. 2001 Feb 27; 98(5):2707-11. PMID: 11226304.
      Citations:    
    174. Sly WS, Vogler C, Grubb JH, Zhou M, Jiang J, Zhou XY, Tomatsu S, Bi Y, Snella EM. Active site mutant transgene confers tolerance to human beta-glucuronidase without affecting the phenotype of MPS VII mice. Proc Natl Acad Sci U S A. 2001 Feb 27; 98(5):2205-10. PMID: 11226217.
      Citations:    
    175. Sukegawa K, Nakamura H, Kato Z, Tomatsu S, Monta?o AM, Fukao T, Toietta G, Tortora P, Orii T, Kondo N. Biochemical and structural analysis of missense mutations in N-acetylgalactosamine-6-sulfate sulfatase causing mucopolysaccharidosis IVA phenotypes. Hum Mol Genet. 2000 May 22; 9(9):1283-90. PMID: 10814710.
      Citations:    
    176. Parkkila S, Parkkila AK, Waheed A, Britton RS, Zhou XY, Fleming RE, Tomatsu S, Bacon BR, Sly WS. Cell surface expression of HFE protein in epithelial cells, macrophages, and monocytes. Haematologica. 2000 Apr; 85(4):340-5. PMID: 10756356.
      Citations:    
    177. Monta?o AM, Yamagishi A, Tomatsu S, Fukuda S, Copeland NG, Orii KE, Isogai K, Yamada N, Kato ZI, Jenkins NA, Gilbert DJ, Sukegawa K, Orii T, Kondo N. The mouse N-acetylgalactosamine-6-sulfate sulfatase (Galns) gene: cDNA isolation, genomic characterization, chromosomal assignment and analysis of the 5'-flanking region. Biochim Biophys Acta. 2000 Mar 17; 1500(3):323-34. PMID: 10699374.
      Citations:    
    178. Fleming RE, Migas MC, Holden CC, Waheed A, Britton RS, Tomatsu S, Bacon BR, Sly WS. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc Natl Acad Sci U S A. 2000 Feb 29; 97(5):2214-9. PMID: 10681454.
      Citations:    
    179. Iwata S, Sukegawa K, Kokuryu M, Tomatsu S, Kondo N, Iwasa S, Orii T. Glycosaminoglycans in neonatal urine. Arch Dis Child Fetal Neonatal Ed. 2000 Jan; 82(1):F78. PMID: 10702001.
      Citations:    
    180. Islam MR, Waheed A, Shah GN, Tomatsu S, Sly WS. Human egasyn binds beta-glucuronidase but neither the esterase active site of egasyn nor the C terminus of beta-glucuronidase is involved in their interaction. Arch Biochem Biophys. 1999 Dec 01; 372(1):53-61. PMID: 10562416.
      Citations:    
    181. Islam MR, Tomatsu S, Shah GN, Grubb JH, Jain S, Sly WS. Active site residues of human beta-glucuronidase. Evidence for Glu(540) as the nucleophile and Glu(451) as the acid-base residue. J Biol Chem. 1999 Aug 13; 274(33):23451-5. PMID: 10438523.
      Citations:    
    182. Fleming RE, Migas MC, Zhou X, Jiang J, Britton RS, Brunt EM, Tomatsu S, Waheed A, Bacon BR, Sly WS. Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1. Proc Natl Acad Sci U S A. 1999 Mar 16; 96(6):3143-8. PMID: 10077651.
      Citations:    
    183. Waheed A, Parkkila S, Saarnio J, Fleming RE, Zhou XY, Tomatsu S, Britton RS, Bacon BR, Sly WS. Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum. Proc Natl Acad Sci U S A. 1999 Feb 16; 96(4):1579-84. PMID: 9990067.
      Citations:    
    184. Rafiqul Islam M, Gallegos Arreola MP, Wong P, Tomatsu S, Corona JS, Sly WS. Beta-glucuronidase P408S, P415L allele in a Mexican population: population screening in Guadalajara and prenatal diagnosis. Prenat Diagn. 1998 Aug; 18(8):822-5. PMID: 9742570.
      Citations:    
    185. Zhou XY, Tomatsu S, Fleming RE, Parkkila S, Waheed A, Jiang J, Fei Y, Brunt EM, Ruddy DA, Prass CE, Schatzman RC, O'Neill R, Britton RS, Bacon BR, Sly WS. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci U S A. 1998 Mar 03; 95(5):2492-7. PMID: 9482913.
      Citations:    
    186. Yamada Y, Kato K, Sukegawa K, Tomatsu S, Fukuda S, Emura S, Kojima S, Matsuyama T, Sly WS, Kondo N, Orii T. Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation. Bone Marrow Transplant. 1998 Mar; 21(6):629-34. PMID: 9543069.
      Citations:    
    187. Sukegawa K, Matsuzaki T, Fukuda S, Masuno M, Fukao T, Kokuryu M, Iwata S, Tomatsu S, Orii T, Kondo N. Brother/sister siblings affected with Hunter disease: evidence for skewed X chromosome inactivation. Clin Genet. 1998 Feb; 53(2):96-101. PMID: 9611068.
      Citations:    
    188. Isogai K, Sukegawa K, Tomatsu S, Fukao T, Song XQ, Yamada Y, Fukuda S, Orii T, Kondo N. Mutation analysis in the iduronate-2-sulphatase gene in 43 Japanese patients with mucopolysaccharidosis type II (Hunter disease). J Inherit Metab Dis. 1998 Feb; 21(1):60-70. PMID: 9501270.
      Citations:    
    189. Tomatsu S, Fukuda S, Cooper A, Wraith JE, Yamagishi A, Kato Z, Yamada N, Isogai K, Sukegawa K, Suzuki Y, Shimozawa N, Kondo N, Orii T. Fifteen polymorphisms in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene: diagnostic implications in Morquio disease. Hum Mutat. 1998; Suppl 1:S42-6. PMID: 9452036.
      Citations:    
    190. Sukegawa K, Tomatsu S, Kondo N, Orii T. [Mucopolysaccharidosis type VII (Sly disease)]. Ryoikibetsu Shokogun Shirizu. 1998; (19 Pt 2):449-52. PMID: 9645106.
      Citations:    
    191. Shimozawa N, Suzuki Y, Tomatsu S, Nakamura H, Kono T, Takada H, Tsukamoto T, Fujiki Y, Orii T, Kondo N. A novel mutation, R125X in peroxisome assembly factor-1 responsible for Zellweger syndrome. Hum Mutat. 1998; Suppl 1:S134-6. PMID: 9452066.
      Citations:    
    192. Sukegawa K, Tomatsu S, Kondo N, Orii T. [Mucopolysaccharidosis type II (Hunter syndrome)]. Ryoikibetsu Shokogun Shirizu. 1998; (19 Pt 2):435-8. PMID: 9645102.
      Citations:    
    193. Sukegawa K, Tomatsu S, Kondo N, Orii T. [Mucopolysaccharidosis type III (Sanfilippo syndrome)]. Ryoikibetsu Shokogun Shirizu. 1998; (19 Pt 2):439-41. PMID: 9645103.
      Citations:    
    194. Sukegawa K, Tomatsu S, Kondo N, Orii T. [Mucopolysaccharidosis type IV (Morquio syndrome, beta-galactosidase deficiency)]. Ryoikibetsu Shokogun Shirizu. 1998; (19 Pt 2):442-5. PMID: 9645104.
      Citations:    
    195. Sukegawa K, Tomatsu S, Kondo N, Orii T. [Mucopolysaccharidosis type I (Hurler syndrome, Scheie syndrome)]. Ryoikibetsu Shokogun Shirizu. 1998; (19 Pt 2):431-4. PMID: 9645101.
      Citations:    
    196. Yamada N, Fukuda S, Tomatsu S, Muller V, Hopwood JJ, Nelson J, Kato Z, Yamagishi A, Sukegawa K, Kondo N, Orii T. Molecular heterogeneity in mucopolysaccharidosis IVA in Australia and Northern Ireland: nine novel mutations including T312S, a common allele that confers a mild phenotype. Hum Mutat. 1998; 11(3):202-8. PMID: 9521421.
      Citations:    
    197. Sukegawa K, Tomatsu S, Kondo N, Orii T. [Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome)]. Ryoikibetsu Shokogun Shirizu. 1998; (19 Pt 2):446-8. PMID: 9645105.
      Citations:    
    198. Parkkila S, Waheed A, Britton RS, Bacon BR, Zhou XY, Tomatsu S, Fleming RE, Sly WS. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci U S A. 1997 Nov 25; 94(24):13198-202. PMID: 9371823.
      Citations:    
    199. Waheed A, Parkkila S, Zhou XY, Tomatsu S, Tsuchihashi Z, Feder JN, Schatzman RC, Britton RS, Bacon BR, Sly WS. Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci U S A. 1997 Nov 11; 94(23):12384-9. PMID: 9356458.
      Citations:    
    200. Kato Z, Fukuda S, Tomatsu S, Vega H, Yasunaga T, Yamagishi A, Yamada N, Valencia A, Barrera LA, Sukegawa K, Orii T, Kondo N. A novel common missense mutation G301C in the N-acetylgalactosamine-6-sulfate sulfatase gene in mucopolysaccharidosis IVA. Hum Genet. 1997 Nov; 101(1):97-101. PMID: 9385378.
      Citations:    
    201. Fukuda S, Yamada N, Tomatsu S, Sukegawa K, Monta?o AM, Hopwood JJ, Muller V, Orii T, Kondo N. Mucopolysaccharidosis IVA: a novel splice acceptor site mutation in intron 4 of the N-acetylgalactosamine-6-sulfate sulfatase gene in an Afghanistan girl with classical Morquio disease. Jpn J Hum Genet. 1997 Jun; 42(2):317-22. PMID: 9290256.
      Citations:    
    202. Bunge S, Kleijer WJ, Tylki-Szymanska A, Steglich C, Beck M, Tomatsu S, Fukuda S, Poorthuis BJ, Czartoryska B, Orii T, Gal A. Identification of 31 novel mutations in the N-acetylgalactosamine-6-sulfatase gene reveals excessive allelic heterogeneity among patients with Morquio A syndrome. Hum Mutat. 1997; 10(3):223-32. PMID: 9298823.
      Citations:    
    203. Sukegawa K, Song XQ, Masuno M, Fukao T, Shimozawa N, Fukuda S, Isogai K, Nishio H, Matsuo M, Tomatsu S, Kondo N, Orii T. Hunter disease in a girl caused by R468Q mutation in the iduronate-2-sulfatase gene and skewed inactivation of the X chromosome carrying the normal allele. Hum Mutat. 1997; 10(5):361-7. PMID: 9375851.
      Citations:    
    204. Tomatsu S, Fukuda S, Cooper A, Wraith JE, Ferreira P, Di Natale P, Tortora P, Fujimoto A, Kato Z, Yamada N, Isogai K, Yamagishi A, Sukegawa K, Suzuki Y, Shimozawa N, Kondo N, Sly WS, Orii T. Fourteen novel mucopolysaccharidosis IVA producing mutations in GALNS gene. Hum Mutat. 1997; 10(5):368-75. PMID: 9375852.
      Citations:    
    205. Fukuda S, Shimozawa N, Suzuki Y, Zhang Z, Tomatsu S, Tsukamoto T, Hashiguchi N, Osumi T, Masuno M, Imaizumi K, Kuroki Y, Fujiki Y, Orii T, Kondo N. Human peroxisome assembly factor-2 (PAF-2): a gene responsible for group C peroxisome biogenesis disorder in humans. Am J Hum Genet. 1996 Dec; 59(6):1210-20. PMID: 8940266.
      Citations:    
    206. Inoue K, Suzuki Y, Yajima S, Shimozawa N, Tomatsu S, Orii T, Kondo N. Carrier identification of X-linked adrenoleukodystrophy by measurement of very long chain fatty acids and lignoceric acid oxidation. Clin Genet. 1996 Nov; 50(5):348-52. PMID: 9007322.
      Citations:    
    207. Cole DE, Fukuda S, Gordon BA, Rip JW, LeCouteur AN, Rupar CA, Tomatsu S, Ogawa T, Sukegawa K, Orii T. Heteroallelic missense mutations of the galactosamine-6-sulfate sulfatase (GALNS) gene in a mild form of Morquio disease (MPS IVA). Am J Med Genet. 1996 Jun 28; 63(4):558-65. PMID: 8826435.
      Citations:    
    208. Tomatsu S, Fukuda S, Yamagishi A, Cooper A, Wraith JF, Hori T, Kato Z, Yamada N, Isogai K, Sukegawa K, Kondo N, Suzuki Y, Shimozawa N, Orii T. Mucopolysaccharidosis IVA: four new exonic mutations in patients with N-acetylgalactosamine-6-sulfate sulfatase deficiency. Am J Hum Genet. 1996 May; 58(5):950-62. PMID: 8651279.
      Citations:    
    209. Shimozawa N, Suzuki Y, Tomatsu S, Tsukamoto T, Osumi T, Fujiki Y, Kamijo K, Hashimoto T, Kondo N, Orii T. Correction by gene expression of biochemical abnormalities in fibroblasts from Zellweger patients. Pediatr Res. 1996 May; 39(5):812-5. PMID: 8726233.
      Citations:    
    210. Fukuda S, Tomatsu S, Masuno M, Ogawa T, Yamagishi A, Rezvi GM, Sukegawa K, Shimozawa N, Suzuki Y, Kondo N, Imaizumi K, Kuroki Y, Okabe T, Orii T. Mucopolysaccharidosis IVA: submicroscopic deletion of 16q24.3 and a novel R386C mutation of N-acetylgalactosamine-6-sulfate sulfatase gene in a classical Morquio disease. Hum Mutat. 1996; 7(2):123-34. PMID: 8829629.
      Citations:    
    211. Rezvi GM, Tomatsu S, Fukuda S, Yamagishi A, Cooper A, Wraith JE, Iwata H, Kato Z, Yamada N, Sukegawa K, Shimozawa N, Suzuki Y, Kondo N, Orii T. Mucopolysaccharidosis IVA: a comparative study of polymorphic DNA haplotypes in the Caucasian and Japanese populations. J Inherit Metab Dis. 1996; 19(3):301-8. PMID: 8803772.
      Citations:    
    212. Fukuda S, Tomatsu S, Cooper A, Wraith JE, Kato Z, Yamada N, Isogai K, Sukegawa K, Kondo N, Orii T. Mucopolysaccharidosis IVA (Morquio A): three novel small deletions in the N-acetylgalactosamine-6-sulfate sulfatase gene. Hum Mutat. 1996; 8(2):187-90. PMID: 8844220.
      Citations:    
    213. Yamagishi A, Tomatsu S, Fukuda S, Uchiyama A, Shimozawa N, Suzuki Y, Kondo N, Sukegawa K, Orii T. Mucopolysaccharidosis type I: identification of common mutations that cause Hurler and Scheie syndromes in Japanese populations. Hum Mutat. 1996; 7(1):23-9. PMID: 8664897.
      Citations:    
    214. Fukuda S, Sukegawa K, Tomatsu S, Orii T. [Mucopolysaccharidoses]. Nihon Rinsho. 1995 Dec; 53(12):3019-24. PMID: 8577052.
      Citations:    
    215. Tomatsu S, Fukuda S, Cooper A, Wraith JE, Rezvi GM, Yamagishi A, Yamada N, Kato Z, Isogai K, Sukegawa K, et al. Mucopolysaccharidosis IVA: identification of a common missense mutation I113F in the N-Acetylgalactosamine-6-sulfate sulfatase gene. Am J Hum Genet. 1995 Sep; 57(3):556-63. PMID: 7668283.
      Citations:    
    216. Hori T, Tomatsu S, Nakashima Y, Uchiyama A, Fukuda S, Sukegawa K, Shimozawa N, Suzuki Y, Kondo N, Horiuchi T, et al. Mucopolysaccharidosis type IVA: common double deletion in the N-acetylgalactosamine-6-sulfatase gene (GALNS). Genomics. 1995 Apr 10; 26(3):535-42. PMID: 7607677.
      Citations:    
    217. Tomatsu S, Fukuda S, Cooper A, Wraith JE, Uchiyama A, Hori T, Nakashima Y, Yamada N, Sukegawa K, Kondo N, et al. Mucopolysaccharidosis IVA: structural gene alterations identified by Southern blot analysis and identification of racial differences. Hum Genet. 1995 Apr; 95(4):376-81. PMID: 7705830.
      Citations:    
    218. Yamada S, Tomatsu S, Sly WS, Islam R, Wenger DA, Fukuda S, Sukegawa K, Orii T. Four novel mutations in mucopolysaccharidosis type VII including a unique base substitution in exon 10 of the beta-glucuronidase gene that creates a novel 5'-splice site. Hum Mol Genet. 1995 Apr; 4(4):651-5. PMID: 7633414.
      Citations:    
    219. Tomatsu S, Fukuda S, Cooper A, Wraith JE, Rezvi GM, Yamagishi A, Yamada N, Kato Z, Isogai K, Sukegawa K, et al. Mucopolysaccharidosis type IVA: identification of six novel mutations among non-Japanese patients. Hum Mol Genet. 1995 Apr; 4(4):741-3. PMID: 7633425.
      Citations:    
    220. Iwata H, Tomatsu S, Fukuda S, Uchiyama A, Rezvi GM, Ogawa T, Hori T, Nakashima Y, Yamagishi A, Sukegawa K, et al. Mucopolysaccharidosis IVA: polymorphic haplotypes and informative RFLPs in the Japanese population. Hum Genet. 1995 Mar; 95(3):257-64. PMID: 7532616.
      Citations:    
    221. Ogawa T, Tomatsu S, Fukuda S, Yamagishi A, Rezvi GM, Sukegawa K, Kondo N, Suzuki Y, Shimozawa N, Or? T. Mucopolysaccharidosis IVA: screening and identification of mutations of the N-acetylgalactosamine-6-sulfate sulfatase gene. Hum Mol Genet. 1995 Mar; 4(3):341-9. PMID: 7795586.
      Citations:    
    222. Tomatsu S, Fukuda S, Uchiyama A, Hori T, Nakashima Y, Sukegawa K, Kondo N, Suzuki Y, Shimozawa N, Orii T. Polymerase chain reaction detection of two novel human N-acetylgalactosamine-6-sulfate sulfatase gene polymorphisms by single-strand conformation polymorphism analysis or by StyI and StuI cleavages. Hum Genet. 1995 Feb; 95(2):243-4. PMID: 7860078.
      Citations:    
    223. Sukegawa K, Tomatsu S, Fukao T, Iwata H, Song XQ, Yamada Y, Fukuda S, Isogai K, Orii T. Mucopolysaccharidosis type II (Hunter disease): identification and characterization of eight point mutations in the iduronate-2-sulfatase gene in Japanese patients. Hum Mutat. 1995; 6(2):136-43. PMID: 7581397.
      Citations:    
    224. Fujii H, Kondo N, Agata H, Fukutomi O, Shinoda S, Kuwabara N, Tomatsu S, Kondo T, Inoue R, Orii T. Genetic analysis of IgE and the IGHE, IGHEP1 and IGHEP2 genes in atopic families. Int Arch Allergy Immunol. 1995 Jan; 106(1):62-8. PMID: 7812168.
      Citations:    
    225. Tomatsu S, Fukuda S, Cooper A, Wraith JE, Yamada N, Isogai K, Kato Z, Sukegawa K, Kondo N, Suzuki Y, et al. Two new mutations, Q473X and N487S, in a Caucasian patient with mucopolysaccharidosis IVA (Morquio disease). Hum Mutat. 1995; 6(2):195-6. PMID: 7581409.
      Citations:    
    226. Wu BM, Tomatsu S, Fukuda S, Sukegawa K, Orii T, Sly WS. Overexpression rescues the mutant phenotype of L176F mutation causing beta-glucuronidase deficiency mucopolysaccharidosis in two Mennonite siblings. J Biol Chem. 1994 Sep 23; 269(38):23681-8. PMID: 8089138.
      Citations:    
    227. Kondo N, Takao A, Tomatsu S, Shimozawa N, Suzuki Y, Ogawa T, Iwata H, Orii T. Suppression of IgA production by lymphocytes induced by diphenylhydantoin. J Investig Allergol Clin Immunol. 1994 Sep-Oct; 4(5):255-7. PMID: 7874323.
      Citations:    
    228. Tomatsu S, Fukuda S, Ogawa T, Kato Z, Isogai K, Kondo N, Suzuki Y, Shimozawa N, Sukegawa K, Orii T. A novel splice site mutation in intron 1 of the GALNS gene in a Japanese patient with mucopolysaccharidosis IVA. Hum Mol Genet. 1994 Aug; 3(8):1427-8. PMID: 7987329.
      Citations:    
    229. Tomatsu S, Fukuda S, Iwata H, Ogawa T, Sukegawa K, Orii T. XhoI and SphI RFLPs in the GALNS gene. Hum Mol Genet. 1994 Jul; 3(7):1208. PMID: 7981705.
      Citations:    
    230. Kondo N, Kasahara K, Kameyama T, Suzuki Y, Shimozawa N, Tomatsu S, Nakashima Y, Hori T, Yamagishi A, Ogawa T, et al. Intravenous immunoglobulins suppress immunoglobulin productions by suppressing Ca(2+)-dependent signal transduction through Fc gamma receptors in B lymphocytes. Scand J Immunol. 1994 Jul; 40(1):37-42. PMID: 8029641.
      Citations:    
    231. Uchiyama A, Tomatsu S, Kondo N, Suzuki Y, Shimozawa N, Fukuda S, Sukegawa K, Taki N, Inamori H, Orii T. New Gaucher disease mutations in exon 10: a novel L444R mutation produces a new NciI site the same as L444P. Hum Mol Genet. 1994 Jul; 3(7):1183-4. PMID: 7981693.
      Citations:    
    232. Tomatsu S, Fukuda S, Iwata H, Ogawa T, Sukegawa K, Orii T. Polymorphism in the GALNS gene. Hum Mol Genet. 1994 Jul; 3(7):1208. PMID: 7981704.
      Citations:    
    233. Agata H, Kondo N, Fukutomi O, Hayashi T, Shinoda S, Nishida T, Yomo A, Suzuki Y, Shimozawa N, Tomatsu S, et al. Comparison of allergic diseases and specific IgE antibodies in different parts of Japan. Ann Allergy. 1994 May; 72(5):447-51. PMID: 8179232.
      Citations:    
    234. Kondo N, Agata H, Fukutomi O, Kameyama T, Suzuki Y, Shimozawa N, Tomatsu S, Nakashima Y, Hori T, Yamagishi A, et al. Effects of the antiallergic drug azelastine hydrochloride on proliferative responses of lymphocytes to food antigens in patients with food-sensitive atopic dermatitis. J Investig Allergol Clin Immunol. 1994 Mar-Apr; 4(2):67-70. PMID: 7921329.
      Citations:    
    235. Nakashima Y, Tomatsu S, Hori T, Fukuda S, Sukegawa K, Kondo N, Suzuki Y, Shimozawa N, Orii T. Mucopolysaccharidosis IV A: molecular cloning of the human N-acetylgalactosamine-6-sulfatase gene (GALNS) and analysis of the 5'-flanking region. Genomics. 1994 Mar 01; 20(1):99-104. PMID: 8020961.
      Citations:    
    236. Uchiyama A, Suzuki Y, Song XQ, Fukao T, Imamura A, Tomatsu S, Shimozawa N, Kondo N, Orii T. Identification of a nonsense mutation in ALD protein cDNA from a patient with adrenoleukodystrophy. Biochem Biophys Res Commun. 1994 Jan 28; 198(2):632-6. PMID: 8297373.
      Citations:    
    237. Suzuki Y, Shimozawa N, Kawabata I, Yajima S, Inoue K, Uchida Y, Izai K, Tomatsu S, Kondo N, Orii T. Prenatal diagnosis of peroxisomal disorders. Biochemical and immunocytochemical studies on peroxisomes in human amniocytes. Brain Dev. 1994 Jan-Feb; 16(1):27-31. PMID: 8059925.
      Citations:    
    238. Suzuki Y, Shimozawa N, Yajima S, Tomatsu S, Kondo N, Nakada Y, Akaboshi S, Lai M, Tanabe Y, Hashimoto T, et al. Novel subtype of peroxisomal acyl-CoA oxidase deficiency and bifunctional enzyme deficiency with detectable enzyme protein: identification by means of complementation analysis. Am J Hum Genet. 1994 Jan; 54(1):36-43. PMID: 8279468.
      Citations:    
    239. Tomatsu S, Fukuda S, Uchiyama A, Hori T, Nakashima Y, Kondo N, Suzuki Y, Shimozawa N, Sukegawa K, Orii T. Molecular analysis by Southern blot for the N-acetylgalactosamine-6-sulphate sulphatase gene causing mucopolysaccharidosis IVA in the Japanese population. J Inherit Metab Dis. 1994; 17(5):601-5. PMID: 7837767.
      Citations:    
    240. Nishida T, Kondo N, Agata H, Fukutomi O, Shinoda S, Suzuki Y, Shimozawa N, Tomatsu S, Orii T. Proliferative responses towards native, heat-denatured and pepsin-treated ovalbumin by peripheral blood mononuclear cells from patients with hen's egg-sensitive atopic dermatitis. Biotherapy. 1994; 8(1):33-40. PMID: 7547079.
      Citations:    
    241. Kondo N, Inoue R, Agata H, Suzuki Y, Shimozawa N, Tomatsu S, Nakashima Y, Yamagishi A, Ogawa T, Orii T. Expression of secreted immunoglobulin heavy chain genes and immunoglobulin-secreting cells in human lymphocytes. Scand J Immunol. 1993 Oct; 38(4):320-2. PMID: 8210995.
      Citations:    
    242. Yamada Y, Tomatsu S, Sukegawa K, Suzuki Y, Kondo N, Hopwood JJ, Orii T. Mucopolysaccharidosis type II (Hunter disease): 13 gene mutations in 52 Japanese patients and carrier detection in four families. Hum Genet. 1993 Sep; 92(2):110-4. PMID: 8370574.
      Citations:    
    243. Orii T, Tomatsu S, Fukuda S, Sukegawa K, Kondo N. [Mucopolysaccharidosis type VII: characterization of exonic point mutations and molecular heterogeneity]. Nihon Rinsho. 1993 Sep; 51(9):2330-5. PMID: 8411710.
      Citations:    
    244. Shinoda S, Kondo N, Fukutomi O, Agata H, Suzuki Y, Shimozawa N, Tomatsu S, Yamada Y, Takemura M, Noma A, et al. Suppressive effects of elimination diets on T cell responses to ovalbumin in hen's egg-sensitive atopic dermatitis patients. Clin Exp Allergy. 1993 Aug; 23(8):689-95. PMID: 8106132.
      Citations:    
    245. Masuno M, Tomatsu S, Nakashima Y, Hori T, Fukuda S, Masue M, Sukegawa K, Orii T. Mucopolysaccharidosis IV A: assignment of the human N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene to chromosome 16q24. Genomics. 1993 Jun; 16(3):777-8. PMID: 8325655.
      Citations:    
    246. Fukuda S, Tomatsu S, Masue M, Sukegawa K, Iwata H, Ogawa T, Nakashima Y, Hori T, Yamagishi A, Hanyu Y, et al. Mucopolysaccharidosis type IVA. N-acetylgalactosamine-6-sulfate sulfatase exonic point mutations in classical Morquio and mild cases. J Clin Invest. 1992 Sep; 90(3):1049-53. PMID: 1522213.
      Citations:    
    247. Okamoto H, Sukegawa K, Tomatsu S, Suzuki Y, Orii T. Optimization of electroporation for transfection of human fibroblast cell lines with origin-defective SV40 DNA: development of human transformed fibroblast cell lines with mucopolysaccharidoses (I-VII) Cell Struct Funct. 1992 Apr; 17(2):123-8. PMID: 1318788.
      Citations:    
    248. Sukegawa K, Tomatsu S, Tamai K, Ikeda M, Sasaki T, Masue M, Fukuda S, Yamada Y, Orii T. Intermediate form of mucopolysaccharidosis type II (Hunter disease): a C1327 to T substitution in the iduronate sulfatase gene. Biochem Biophys Res Commun. 1992 Mar 16; 183(2):809-13. PMID: 1550586.
      Citations:    
    249. Tomatsu S, Fukuda S, Masue M, Sukegawa K, Fukao T, Yamagishi A, Hori T, Iwata H, Ogawa T, Nakashima Y, et al. Morquio disease: isolation, characterization and expression of full-length cDNA for human N-acetylgalactosamine-6-sulfate sulfatase. Biochem Biophys Res Commun. 1991 Dec 16; 181(2):677-83. PMID: 1755850.
      Citations:    
    250. Sasaki T, Sukegawa K, Masue M, Fukuda S, Tomatsu S, Orii T. Purification and partial characterization of alpha-N-acetylglucosaminidase from human liver. J Biochem. 1991 Nov; 110(5):842-6. PMID: 1783617.
      Citations:    
    251. Fukao T, Yamaguchi S, Tomatsu S, Orii T, Frauendienst-Egger G, Schrod L, Osumi T, Hashimoto T. Evidence for a structural mutation (347Ala to Thr) in a German family with 3-ketothiolase deficiency. Biochem Biophys Res Commun. 1991 Aug 30; 179(1):124-9. PMID: 1715688.
      Citations:    
    252. Asano J, Tomatsu S, Sukegawa K, Ikedo Y, Minami R, Iida M, Nishimura M, Nakagawa M, Ohshiro M, Orii T. Gene deletions in Japanese patients with Duchenne and Becker muscular dystrophies: deletion study and carrier detection. Clin Genet. 1991 Jun; 39(6):419-24. PMID: 1863988.
      Citations:    
    253. Fukuda S, Tomatsu S, Sukegawa K, Sasaki T, Yamada Y, Kuwahara T, Okamoto H, Ikedo Y, Yamaguchi S, Orii T. Molecular analysis of mucopolysaccharidosis type VII. J Inherit Metab Dis. 1991; 14(5):800-4. PMID: 1779626.
      Citations:    
    254. Tomatsu S, Fukuda S, Sukegawa K, Ikedo Y, Yamada S, Yamada Y, Sasaki T, Okamoto H, Kuwahara T, Yamaguchi S, et al. Mucopolysaccharidosis type VII: characterization of mutations and molecular heterogeneity. Am J Hum Genet. 1991 Jan; 48(1):89-96. PMID: 1702266.
      Citations:    
    255. Tomatsu S, Fukuda S, Sukegawa K, Yamaguchi S, Sasaki T, Ikedo Y, Orii T. [Molecular basis of mucopolysaccaridosis type VII (beta-glucuronidase deficiency)]. Rinsho Byori. 1990 Sep; 38(9):1027-35. PMID: 2232263.
      Citations:    
    256. Asano J, Tomatsu S, Sukegawa K, Yamaguchi S, Ikedo Y, Minami R, Iida M, Nishimura M, Nakagawa M, Ohshiro M, et al. Gene deletions in Japanese patients with Duchenne and Becker muscular dystrophy. Jinrui Idengaku Zasshi. 1990 Jun; 35(2):159-68. PMID: 2398631.
      Citations:    
    257. Tomatsu S, Sukegawa K, Ikedo Y, Fukuda S, Yamada Y, Sasaki T, Okamoto H, Kuwabara T, Orii T. Molecular basis of mucopolysaccharidosis type VII: replacement of Ala619 in beta-glucuronidase with Val. Gene. 1990 May 14; 89(2):283-7. PMID: 2115490.
      Citations:    
    258. Masuno M, Tomatsu S, Sukegawa K, Orii T. Non-existence of a tight association between a 444leucine to proline mutation and phenotypes of Gaucher disease: high frequency of a NciI polymorphism in the non-neuronopathic form. Hum Genet. 1990 Jan; 84(2):203-6. PMID: 1967589.
      Citations:    
    259. Tomatsu S, Kobayashi Y, Fukumaki Y, Yubisui T, Orii T, Sakaki Y. The organization and the complete nucleotide sequence of the human NADH-cytochrome b5 reductase gene. Gene. 1989 Aug 15; 80(2):353-61. PMID: 2479590.
      Citations:    
    260. Takami T, Sasaki T, Tomatsu S, Sukegawa K, Orii T. [Inherited storage disease associated mononuclear phagocytic system]. Nihon Rinsho. 1989 Mar; 47(3):664-8. PMID: 2499707.
      Citations:    
    261. Shiokawa S, Fucharoen S, Fucharoen G, Tomatsu S, Fukumaki Y. Heterogeneity of the gamma-globin gene sequences in Japanese individuals: implication of gene conversion in generation of polymorphisms. J Biochem. 1989 Feb; 105(2):184-9. PMID: 2566597.
      Citations:    
    262. Toki F, Oi I, Saito A, Shindo H, Tomatsu S, Shibata I, Kozu T, Takeuchi T. [A case of chronic dorsal pancreatitis (author's transl)]. Nihon Shokakibyo Gakkai Zasshi. 1980 Apr; 77(4):634-7. PMID: 7382154.
      Citations:    
    263. Toki F, Oi I, Saito S, Tomatsu S, Kozu T, Takeuchi T, Hara T, Suzuki S, Nakamura M, Kobayashi S, Hanyu F. [Two cases of congenital choledochal cyst with translucent pancreatic stone (author's transl)]. Nihon Shokakibyo Gakkai Zasshi. 1979 May; 76(5):1146-51. PMID: 459144.
      Citations:    
    Tomatsu's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (652)
    Explore
    _
    Co-Authors (20)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _